View printer-friendly version << Back
Dany Garcia Elected to Pediatrix's Board of Directors

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Nov. 5, 2008--Pediatrix Medical Group, Inc., (NYSE:PDX) today announced that its Board of Directors has elected Dany Garcia, the founder and Chief Executive Officer of Miami-based investment advisory firm JDM Partners LLC, to a newly created seat.

Ms. Garcia, 39, is a prominent South Florida entrepreneur and philanthropist. She founded JDM Partners in 2002, which provides investment counsel to high net worth individuals, families and corporations through traditional investment advisory services as well as alternative opportunities including equity, real estate and entertainment industry investments.

She also serves as Chairman for White Buffalo Productions and is Executive Producer on such projects as the recently released documentary Theater of War, starring Meryl Streep and Kevin Kline.

Ms. Garcia is also founder and president of The Beacon Experience, a Foundation for Success, which provides educational and social tutoring opportunities for at-risk children. In addition, Ms. Garcia is co-founder and vice president of The Rock Foundation, a children's charity, and is a member of the national board of the "I Have a Dream" Foundation.

Ms. Garcia is a member of the University of Miami Board of Trustees, and a Director of the Florida International University Foundation Board.

About Pediatrix

Pediatrix Medical Group, Inc. is the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services and recently expanded to include anesthesiology services. Pediatrix physicians and advanced practitioners are reshaping the delivery of care within the maternal-fetal, neonatal intensive care and pediatric cardiology subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Founded in 1979, its neonatal physicians provide services at more than 250 neonatal intensive care units, and in many markets they collaborate with affiliated maternal-fetal medicine, pediatric cardiology physician subspecialists and pediatric intensivists to provide a clinical care continuum. Combined, Pediatrix and its affiliated professional corporations employ more than 1,200 physicians in 32 states and Puerto Rico. Pediatrix is also the nation's largest provider of newborn hearing screens. Additional information is available at

Certain statements and information in this press release may be deemed to be "forward-looking statements" within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as "believe", "hope", "may", "anticipate", "should", "intend", "plan", "will", "expect", "estimate", "project", "positioned", "strategy" and similar expressions, and are based on assumptions and assessments made by Pediatrix's management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and Pediatrix undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in Pediatrix's most recent Annual Report on Form 10-K, including the section entitled "Risk Factors".

    CONTACT: Pediatrix Medical Group, Inc., Fort Lauderdale
             Bob Kneeley, Director, Investor Relations,
             954-384-0175, x-5300

    SOURCE: Pediatrix Medical Group, Inc.